Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
Abstract To evaluate the age-related efficacy and safety of atropine 0.01% eye drops over 2 years for myopia control in a multicentric pediatric Spanish cohort. A non-controlled, interventional, prospective multicenter study was conducted as an extension of the Spanish Group of Atropine Treatment fo...
Main Authors: | Inés Pérez-Flores, Beatriz Macías-Murelaga, Multicenter Group of Atropine Treatment for Myopia Control (GTAM), Jesús Barrio-Barrio |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43569-x |
Similar Items
-
Effects of atropine 0.01% on refractive errors in children with myopia
by: Xingxue Zhu, et al.
Published: (2023-08-01) -
Effect of orthokeratology combined with 0.01% atropine solution on adolescents with myopia
by: Ying Liu, et al.
Published: (2023-08-01) -
Effect of 0.01% Atropine on diopter and optic axis in adolescents and children with myopia
by: Liping Xia, et al.
Published: (2023-02-01) -
Effectiveness of 0.01% atropine in anisomyopic children
by: Azfira Hussain, et al.
Published: (2023-01-01) -
Efficacy of topical low-dose atropine eye drops (0.01%) in slowing myopia progression in school-age children
by: Yashi Bansal, et al.
Published: (2024-01-01)